Chris van Ingen, the head of Agilent Technologies’ Life Sciences and Chemical Analysis business unit, told analysts Monday that there is a “resurgence” in DNA analysis based on microarray-based applications for comparative genomic hybridization and location analysis.

Microarray analysis of RNA is the larger part of the microarray market, where Agilent is considered the No. 2 player after dominant Affymetrix. It’s a market that is regarded as nearing maturity, with sales growth leveling off as whole-genome microarrays move toward near-commodity status.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.